Xiamen Amoytop Biotech Co., Ltd.

This study is testing a new weekly growth hormone injection for children with idiopathic short stature, which means they are short for no known medical reason. It will compare the new weekly shot to the standard daily growth hormone injection to see if it works as well and is saf…

This study is testing a medication called peginterferon alfa-2b for adults with essential thrombocythemia, a blood disorder that causes high platelet counts and increases clotting risk. It's specifically for patients who cannot take or don't respond to the standard first-line tre…

This study is testing a new weekly growth hormone injection to see if it helps children with short stature who were born small for their gestational age grow faster. It will compare the new weekly shot to the standard daily growth hormone treatment. The goal is to see if the new …